Wockhardt Sells Animal Health Div To France's Vetoquinol

June 28 2009, 06:50:54 IST | REUTERS

The animal healthcare business posted operating profit of Rs 18 cr on net sales of Rs 77 cr for the year ended Dec 2008.

Indian pharma company Wockhardt Ltd said on Sunday it had signed an agreement to divest its Animal Health Division to France's Vetoquinol, but did not provide any financial details on the deal. (Editor: The Economic Times reported that the deal size could be anywhere between Rs 170-180 crore.)

"For Wockhardt this initiative to divest its non-core business is a step towards its continued growth plan and a firm focus on its core human pharmaceutical business," it said in a statement.

"Wockhardt is re-inventing itself by taking fundamentally strong and positive steps by restructuring and rationalising its businesses to raise fresh capital and gain investor confidence," it said.

The transaction would take effect in the second half of 2009, it added. Earlier this month the company obtained shareholders' approval to transfer, sell or dispose off its Animal Health Business for about 1.5 billion rupees ($31.2 million).

For the year ended December 2008, the animal healthcare business posted operating profit of 180 million rupees on net sales of 770 million rupees.

Vetoquinol is an independent, family-owned veterinary pharmaceutical laboratory.

Comments

Post new comment

The STAR Amalgamation: No Indian tax Liability for Transfer of Shares

RAMYA KRISHNAN, NISHITH DESAI ASSOCIATES

The judiciary has yet again recognized the principles laid down in Azadi Bachao Andolan’s case.

Distressed Assets Investing – An Emerging Private Equity Strategy

SARFARAZ AGBOATWALA & RISHIKA CHANDAN, ISB

The addition of distressed assets to a Fund Manager’s portfolio must compensate for the risks associated with it.

» See All

VCCircle